Description
The marker is associated with changes in methionine metabolism. It is investigated to identify genetic predisposition to hyperhomocysteinemia, vascular diseases, anemia, ischemic heart disease, ischemic stroke, hypertension, thrombosis, retinal artery occlusion, preeclampsia, various forms of cancer, primary glaucoma, migraines, depression, schizophrenia, and in the fetus: neural tube defects, Down syndrome, and cleft lip. It is informative for prescribing folic acid and for dietary recommendations (vitamin K). OMIM: 607093.
Period of execution
Within 6 days. The specified time does not include the day of biomaterial collection
Biomaterial type
- Buccal (cheek) epithelium
- Venous blood